These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial. Johnson TW; Kay IP; Ormiston JA Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074 [TBL] [Abstract][Full Text] [Related]
28. Pericardial patch on coronary aneurysm. Nakamura T Ann Thorac Surg; 2009 Jan; 87(1):351; author reply 351-2. PubMed ID: 19101341 [No Abstract] [Full Text] [Related]
29. The use of drug-eluting stents in venous coronary artery bypass grafts. Hernandez-Antolín R; Alfonso F; Jimenez P EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072 [TBL] [Abstract][Full Text] [Related]
30. Dramatic increase in use of coronary stents. Lane DM Am J Cardiol; 1999 Nov; 84(9):1141. PubMed ID: 10569689 [No Abstract] [Full Text] [Related]
31. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384 [TBL] [Abstract][Full Text] [Related]
32. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921 [TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509 [TBL] [Abstract][Full Text] [Related]
34. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. Cohen M Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347 [TBL] [Abstract][Full Text] [Related]
35. Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery. Sheiban I; Moretti C; Biondi-Zoccai GG; Sciuto F; Omedè P; Lombardi P; Meliga E; Reviglione M; Ballari GP; Bollati M; Gambino A; Trevi G J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):213-6. PubMed ID: 18192822 [No Abstract] [Full Text] [Related]
36. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897 [TBL] [Abstract][Full Text] [Related]
38. Quality of life with PCI versus medical therapy in stable coronary disease. Brown RA; Teirstein PS; Kandzari DE N Engl J Med; 2008 Nov; 359(21):2291; author reply 2292-3. PubMed ID: 19031543 [No Abstract] [Full Text] [Related]
39. Introduction. Waksman R Am J Cardiol; 2007 Oct; 100(8B):S1-2. PubMed ID: 17950826 [No Abstract] [Full Text] [Related]
40. Recanalization of chronically occluded coronaries: a step forward in understanding its impact. Lemos PA Catheter Cardiovasc Interv; 2008 May; 71(6):E5-6. PubMed ID: 18412091 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]